Since the approval of Wegovy for weight loss in 2021, Hollywood celebrities, social media influencers and even billionaire tech mogul Elon Musk have reportedly used Wegovy to get rid of unwanted weight.
Its popularity resulted in shortages in the supply of Wegovy.
Ozempic was quickly being pushed to be prescribed off-label for weight loss, although it is not labelled for it. This resulted in a shortage of Ozempic as well in the United States, Australia and Europe. Diabetic uses of Ozempic in these countries went scrambling in search of the supply or turn to other alternatives.
Closer to home, Singapore’s HSA reported that four listings of Ozempic and Wegovy have to be removed from sellers on local e-commerce platforms since the start of 2023.
In Singapore, Rybelsus, Ozempic and Wegovy can only be supplied upon a valid prescription.
Although effective, Wegovy is not a weight loss miracle. Weight regain can be expected after discontinuation of the medication.
Furthermore, the long-term safety of the Semaglutide family of medications have not been fully established as the majority of clinical trials are less than four years in duration.